Yale University researcher Akiko Iwasaki, Ph.D., says immune profiling shows how Long COVID patients have distinct features not found in control groups. These patients, who also exhibit elevated levels of exhausted T-cells, cause her to express surprise at skeptics.
Iwasaki joins Fiona Lowenstein, editor of “The Long COVID Survival Guide,” to discuss patients who say they’re suffering from Long COVID for as much as two years after their acute phase of the disease.
Iwasaki also explains why her lab’s effort to move forward with a COVID nasal spray faces financial hurdles.
Listen in to this important conversation with hosts Mark Masselli and Margaret Flinter.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Originally broadcast November 13, 2025 What if health care for moms and babies came with…
Originally broadcast November 6, 2025 Intimate partner violence affects more women in the United States…
Food insecurity could soon worsen for millions of families and result in devastating health outcomes.…
Originally broadcast June 5, 2024. A recent report from the Centers for Disease Control and…
Veterans Day, which is less than a month away, is a time to honor and…
Originally broadcast October 9, 2025 $44 billion in drugs that help Americans are purchased through…